Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading
Molecular Therapy · 2023-05 · 31 (5) · 1231-1250
DOI: 10.1016/j.ymthe.2023.02.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Therapy, 2023-05. Verfasst von Julia Rädler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomolecular Medicine, Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institutet, 141 57 Huddinge, Swe…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Exosomes, Cell-Derived Microparticles. Die Arbeit wurde bisher 306-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Extracellular vesicles (EVs) are gaining increasing attention for diagnostic and therapeutic applications in various diseases. These natural nanoparticles benefit from favorable safety profiles and unique biodistribution capabilities, rendering them attractive drug-delivery modalities over synthetic analogs. However, the widespread use of EVs is limited by technological shortcomings and biological knowledge gaps that fail to unravel their heterogeneity. An in-depth understanding of their biogenesis is crucial to unlocking their full therapeutic potential. Here, we explore how knowledge about EV biogenesis can be exploited for EV bioengineering to load therapeutic protein or nucleic acid cargos into or onto EVs. We summarize more than 75 articles and discuss their findings on the formation and composition of exosomes and microvesicles, revealing multiple pathways that may be stimulation and/or cargo dependent. Our analysis further identifies key regulators of natural EV cargo loading and we discuss how this knowledge is integrated to develop engineered EV biotherapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomolecular Medicine, Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institutet, 141 57 Huddinge, Sweden.
- Biomolecular Medicine, Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institutet, 141 57 Huddinge, Sweden; Department of Paediatrics, University of Oxford, Oxford OX3 9DU,…
- Biomolecular Medicine, Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institutet, 141 57 Huddinge, Sweden. Electronic address: samir.el-andaloussi@ki.se.
Zitieren
APA
Rädler, J., Gupta, D., Zickler, A., & Andaloussi, S. E. (2023). Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. Molecular Therapy, 31(5), 1231-1250. https://doi.org/10.1016/j.ymthe.2023.02.013
Vancouver
Rädler J, Gupta D, Zickler A, Andaloussi SE. Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. Molecular Therapy. 2023;31(5):1231-1250. doi:10.1016/j.ymthe.2023.02.013
BibTeX
@article{Rdler2023,
author = {Rädler, Julia and Gupta, Dhanu and Zickler, Antje and Andaloussi, Samir El},
title = {Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading},
journal = {Molecular Therapy},
year = {2023},
volume = {31},
number = {5},
pages = {1231--1250},
doi = {10.1016/j.ymthe.2023.02.013}
}
EUVIMED